UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 29, 2023
Accession Number:
0001493152-23-042520
Submission Type:
POS AM
CIK:
0001595353
Company Name:
Galmed Pharmaceuticals Ltd.
File Number:
333-272722